Investigation of the ubiquitin ligase RNF31 as a mediator of immune evasion in advanced prostate cancer

被引：0
|
作者：
Liu, Tianyi
Li, Haolong
Hua, Tony Junjie
Shin, Hyunjin
Shenoy, Tanushree
Sjoestroem, Martin
Lundberg, Arian
Gilbert, Luke
Quigley, David
Ashworth, Alan
Lanier, Lewis
Feng, Felix
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 11期
关键词：
D O I：
10.1158/1538-7445.PRCA2023-B031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B031
引用
收藏
页数：3
相关论文
共 50 条
  • [31] E3 ubiquitin ligase HECTD2 mediates melanoma progression and immune evasion
    Eleonora Ottina
    Veera Panova
    Laura Doglio
    Anastasiya Kazachenka
    Georgina Cornish
    Joanna Kirkpatrick
    Jan Attig
    George R. Young
    Kevin Litchfield
    Tom Lesluyes
    Peter Van Loo
    Charles Swanton
    James MacRae
    Thomas Tüting
    George Kassiotis
    Oncogene, 2021, 40 : 5567 - 5578
  • [32] The different immune evasion mechanisms in human prostate cancer
    Bou-Dargham, Mayassa J.
    Liu, Yuhang
    Sang, Qing-Xiang Amy
    Zhang, Jinfeng
    CANCER RESEARCH, 2018, 78 (13)
  • [33] The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells
    Deborah Schneider
    Robert Lorenz Chua
    Nicole Molitor
    Feda H. Hamdan
    Eva Maria Rettenmeier
    Evangelos Prokakis
    Vivek Kumar Mishra
    Vijayalakshmi Kari
    Florian Wegwitz
    Steven A. Johnsen
    Robyn Laura Kosinsky
    Clinical Epigenetics, 2019, 11
  • [34] Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187
    Wang, Zhonghao
    Kong, Qiong
    Su, Peng
    Duan, Miao
    Xue, Min
    Li, Xin
    Tang, Jianing
    Gao, Zhitao
    Wang, Beibei
    Li, Zhongbo
    Liu, Yun
    Yang, Xiao
    Cao, Ruilin
    Song, Tingting
    Wang, Ke
    Cai, Yuqing
    Wu, Danfeng
    Li, Jinglei
    Wu, Gaosong
    Guled, Asha M.
    Zhu, Jian
    Yan, Cheng
    Zhuang, Ting
    ONCOGENESIS, 2020, 9 (03)
  • [35] Adenovirus-mediated downregulation of the ubiquitin ligase RNF8 sensitizes bladder cancer to radiotherapy
    Zhao, Mei-Jun
    Song, Yan-Feng
    Niu, Hai-Tao
    Tian, Ying-Xia
    Yang, Xu-Guang
    Xie, Kun
    Jing, Yu-Hong
    Wang, De-Gui
    ONCOTARGET, 2016, 7 (08) : 8956 - 8967
  • [36] Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20
    Iram Fatima
    Rizwan Ahmad
    Susmita Barman
    Saiprasad Gowrikumar
    Kristina Pravoverov
    Mark Primeaux
    Kurt W. Fisher
    Amar B. Singh
    Punita Dhawan
    British Journal of Cancer, 2024, 130 : 1046 - 1058
  • [37] Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20
    Fatima, Iram
    Ahmad, Rizwan
    Barman, Susmita
    Gowrikumar, Saiprasad
    Pravoverov, Kristina
    Primeaux, Mark
    Fisher, Kurt W.
    Singh, Amar B.
    Dhawan, Punita
    BRITISH JOURNAL OF CANCER, 2024, 130 (06) : 1046 - 1058
  • [38] Regulation of Hippo signaling and triple negative breast cancer progression by an ubiquitin ligase RNF187
    Zhonghao Wang
    Qiong Kong
    Peng Su
    Miao Duan
    Min Xue
    Xin Li
    Jianing Tang
    Zhitao Gao
    Beibei Wang
    Zhongbo Li
    Yun Liu
    Xiao Yang
    Ruilin Cao
    Tingting Song
    Ke Wang
    Yuqing Cai
    Danfeng Wu
    Jinglei Li
    Gaosong Wu
    Asha M. Guled
    Jian Zhu
    Cheng Yan
    Ting Zhuang
    Oncogenesis, 9
  • [39] The E3 ubiquitin ligase RNF40 suppresses apoptosis in colorectal cancer cells
    Schneider, Deborah
    Chua, Robert Lorenz
    Molitor, Nicole
    Hamdan, Feda H.
    Rettenmeier, Eva Maria
    Prokakis, Evangelos
    Mishra, Vivek Kumar
    Kari, Vijayalakshmi
    Wegwitz, Florian
    Johnsen, Steven A.
    Kosinsky, Robyn Laura
    CLINICAL EPIGENETICS, 2019, 11 (1)
  • [40] The Ubiquitin Ligase RNF125 Targets Innate Immune Adaptor Protein TRIM14 for Ubiquitination and Degradation
    Jia, Xue
    Zhou, Hongli
    Wu, Chao
    Wu, Qiankun
    Ma, Shichao
    Wei, Congwen
    Cao, Ye
    Song, Jingdong
    Zhong, Hui
    Zhou, Zhuo
    Wang, Jianwei
    JOURNAL OF IMMUNOLOGY, 2017, 198 (12): : 4652 - 4658
12345